StockNews.com Downgrades Addus HomeCare (NASDAQ:ADUS) to Hold

Addus HomeCare (NASDAQ:ADUS) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Thursday.

Several other research firms have also recently weighed in on ADUS. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Oppenheimer increased their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Stephens boosted their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. JMP Securities assumed coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price target on the stock. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $133.67.

Addus HomeCare Price Performance

Shares of ADUS stock traded up $2.05 during mid-day trading on Thursday, hitting $133.32. The company had a trading volume of 121,651 shares, compared to its average volume of 128,775. The stock’s 50 day moving average price is $125.15 and its 200-day moving average price is $126.34. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.12. The company has a market capitalization of $2.42 billion, a P/E ratio of 30.51, a P/E/G ratio of 1.63 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.03 EPS. On average, equities research analysts expect that Addus HomeCare will post 4.58 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 39,750 shares of company stock worth $4,930,750. 4.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds have recently bought and sold shares of ADUS. Texas Permanent School Fund Corp lifted its position in shares of Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after purchasing an additional 82 shares during the last quarter. Inspire Investing LLC increased its stake in Addus HomeCare by 3.3% in the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after buying an additional 100 shares during the period. New York State Teachers Retirement System lifted its holdings in Addus HomeCare by 1.2% during the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after buying an additional 100 shares in the last quarter. Equitable Trust Co. boosted its position in Addus HomeCare by 2.2% in the 3rd quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock valued at $642,000 after buying an additional 106 shares during the period. Finally, Royce & Associates LP grew its stake in Addus HomeCare by 1.2% in the 3rd quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock worth $1,187,000 after acquiring an additional 109 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.